Levis, M. J., Montesinos, P., Kim, H.-J., Vrhovac, R., Patkowska, E., Zak, P., … Erba, H. P. (2024). Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With FLT3-ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial. In Blood (Vol. 144, pp. 848–848). American Society of Hematology. https://doi.org/10.1182/blood-2024-203303

Levis, Mark J., Pau Montesinos, Hee-Je Kim, Radovan Vrhovac, Elzbieta Patkowska, Pavel Zak, Po-Nan Wang, et al. “Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With FLT3-ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial.” In Blood, 144:848–848. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-203303.

Levis MJ, Montesinos P, Kim H-J, Vrhovac R, Patkowska E, Zak P, et al. Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With FLT3-ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial. In: Blood. American Society of Hematology; 2024. p. 848–848.

Levis, Mark J., et al. “Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With FLT3-ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 848–848. Crossref, doi:10.1182/blood-2024-203303.

Levis MJ, Montesinos P, Kim H-J, Vrhovac R, Patkowska E, Zak P, Wang P-N, Cortes JE, Sekeres MA, Dombret H, Amadori S, Wang J, Schlenk RF, Perl AE, Yazawa M, Rohrbach JEC, Thodima V, Chang KCN, Liu L, Imadalou K, Nahar A, Burns K, Erba HP. Correlation of Baseline Gene Mutations With Quizartinib Efficacy in Patients With FLT3-ITD-Positive Newly Diagnosed Acute Myeloid Leukemia in the Phase 3 QuANTUM-First Trial. Blood. American Society of Hematology; 2024. p. 848–848.